List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 891 studies with search of:   Puerto Rico
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
2 Active, not recruiting The DURABLE Trial: Evaluating the Durability of Starter Insulin Regimens in Patients With Type 2 Diabetes (IOOV)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine;   Drug: Humalog Low Mix
3 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
4 Recruiting Fibromyalgia Health Outcome Study on Cost of Treatments
Condition: Fibromyalgia
Intervention:
5 Active, not recruiting Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Drug: Maraviroc (UK-427,857);   Drug: Optimized Background Therapy;   Drug: Optimized Background Therapy;   Drug: Placebo;   Drug: Optimized Background Therapy
6 Recruiting A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Sunitinib + Capecitabine;   Drug: Capecitabine
7 Terminated Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With Humira as Their First Anti-TNF Monoclonal Antibody
Condition: Rheumatoid Arthritis
Intervention: Drug: Humira (adalimumab)
8 Completed A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
Condition: Diabetes
Interventions: Drug: Saxagliptin and Metformin;   Drug: Saxagliptin and Metformin;   Drug: Saxagliptin and Placebo;   Drug: Metformin and Placebo
9 Recruiting A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Condition: Coronary Heart Disease
Interventions: Drug: RO4607381;   Drug: Placebo;   Drug: Evidence-based medical care for Acute Coronary Syndrome
10 Terminated Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 2 Diabetes
Condition: Diabetes Mellitus
Interventions: Drug: Inhaled Insulin;   Drug: Subcutaneous insulin
11 Recruiting A Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy in Dyslipidemic Subjects With Stage 3 Chronic Kidney Disease
Conditions: Dyslipidemias;   Coronary Heart Disease;   Kidney Disease
Interventions: Drug: ABT-335;   Drug: Rosuvastatin;   Drug: Placebo
12 Active, not recruiting The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: liraglutide;   Drug: sitagliptin;   Drug: metformin;   Drug: liraglutide
13 Recruiting Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease
Conditions: Thrombocytopenia;   Hepatitis C
Intervention: Drug: eltrombopag
14 Active, not recruiting A Study to Determine the Optimal Protocol for Treatment Initiation With Methotrexate and Adalimumab Combination Therapy in Patients With Early Rheumatoid Arthritis - OPTIMA
Condition: Rheumatoid Arthritis
Interventions: Biological: Humira (adalimumab) + methotrexate;   Biological: Placebo + methotrexate
15 Recruiting Stress Management Therapy in Patients Receiving Chemotherapy for Cancer
Conditions: Cancer-Related Problem/Condition;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: counseling;   Procedure: management of therapy complications;   Procedure: mind-body intervention procedure;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment;   Procedure: study of socioeconomic and demographic variables
16 Active, not recruiting Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics
Condition: Type 2 Diabetes
Interventions: Drug: INCB013739;   Drug: Placebo
17 Completed A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Saxagliptin;   Drug: Saxagliptin;   Drug: Placebo
18 Active, not recruiting A Study of Paricalcitol Capsules on Reducing Albuminuria in Type 2 Diabetic Nephropathy Being Treated With Renin-Angiotensin System Inhibitors
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease Stages 3 & 4
Interventions: Drug: Zemplar (paricalcitol ) capsules;   Drug: Zemplar (paricalcitol) capsules;   Drug: Placebo
19 Recruiting Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)
Condition: HIV Infection
Interventions: Drug: Elvitegravir;   Drug: Raltegravir
20 Recruiting An Efficacy and Safety Study of TAK-491 Compared to Valsartan and Olmesartan in Subjects With Essential Hypertension.
Condition: Essential Hypertension
Interventions: Drug: TAK-491;   Drug: TAK-491;   Drug: Valsartan;   Drug: Olmesartan;   Drug: Placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services